A Study of Baricitinib in Healthy Japanese Participants

Clinical trial NCT02263911 · COMPLETED

Trial details

NCT number: NCT02263911
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2014-11-01
Primary completion: 2014-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.